[Metabolic effect of intravenously administered glucose, xylose or glycerin in various dosages and combinations].
D000818:Animals; D001786:Blood Glucose / Q000378:metabolism; D002331:Carnitine / Q000008:administration & dosage; D004305:Dose-Response Relationship, Drug; D004359:Drug Therapy, Combination; D004734:Energy Metabolism / Q000187:drug effects*; D005217:Fat Emulsions, Intravenous / Q000008:administration & dosage; D005947:Glucose / Q000008:administration & dosage*; D005950:Glucose Solution, Hypertonic / Q000008:administration & dosage*; D005990:Glycerol / Q000008:administration & dosage*; D006801:Humans; D010288:Parenteral Nutrition / Q000379:methods*; D011182:Postoperative Care / Q000379:methods; D012772:Shock, Septic / Q000628:therapy; D014947:Wounds and Injuries / Q000628:therapy; D014994:Xylose / Q000008:administration & dosage*
D001786:Blood Glucose; D005217:Fat Emulsions, Intravenous; D005950:Glucose Solution, Hypertonic; D014994:Xylose; D005947:Glucose; D005990:Glycerol; D002331:Carnitine
Zur Stoffwechselwirkung von intravenös verabreichter Glukose, Xylit oder Glyzerin während unterschiedlicher Dosierung und Kombination.